These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 38673795)
1. Tumor-Extrinsic Axl Expression Shapes an Inflammatory Microenvironment Independent of Tumor Cell Promoting Axl Signaling in Hepatocellular Carcinoma. Breitenecker K; Heiden D; Demmer T; Weber G; Primorac AM; Hedrich V; Ortmayr G; Gruenberger T; Starlinger P; Herndler-Brandstetter D; Barozzi I; Mikulits W Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673795 [TBL] [Abstract][Full Text] [Related]
2. AXL Knock-Out in SNU475 Hepatocellular Carcinoma Cells Provides Evidence for Lethal Effect Associated with G2 Arrest and Polyploidization. Batur T; Argundogan A; Keles U; Mutlu Z; Alotaibi H; Senturk S; Ozturk M Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948046 [TBL] [Abstract][Full Text] [Related]
3. Role of the receptor tyrosine kinase Axl in hepatocellular carcinoma and its clinical relevance. Niu ZS; Niu XJ; Wang WH Future Oncol; 2019 Feb; 15(6):653-662. PubMed ID: 30648886 [TBL] [Abstract][Full Text] [Related]
4. AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma. Xu MZ; Chan SW; Liu AM; Wong KF; Fan ST; Chen J; Poon RT; Zender L; Lowe SW; Hong W; Luk JM Oncogene; 2011 Mar; 30(10):1229-40. PubMed ID: 21076472 [TBL] [Abstract][Full Text] [Related]
5. Dynamics of Axl Receptor Shedding in Hepatocellular Carcinoma and Its Implication for Theranostics. Holstein E; Binder M; Mikulits W Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30567378 [TBL] [Abstract][Full Text] [Related]
6. Skipping of exon 10 in Shen L; Lei S; Zhang B; Li S; Huang L; Czachor A; Breitzig M; Gao Y; Huang M; Mo X; Zheng Q; Sun H; Wang F Theranostics; 2020; 10(13):5719-5735. PubMed ID: 32483414 [TBL] [Abstract][Full Text] [Related]
7. Hypoxia stabilizes GAS6/Axl signaling in metastatic prostate cancer. Mishra A; Wang J; Shiozawa Y; McGee S; Kim J; Jung Y; Joseph J; Berry JE; Havens A; Pienta KJ; Taichman RS Mol Cancer Res; 2012 Jun; 10(6):703-12. PubMed ID: 22516347 [TBL] [Abstract][Full Text] [Related]
8. Axl and autophagy LC3 expression in tumors is strongly associated with clinical prognosis of hepatocellular carcinoma patients after curative resection. Hsu CC; Hsieh PM; Chen YS; Lo GH; Lin HY; Dai CY; Huang JF; Chuang WL; Chen YL; Yu ML; Lin CW Cancer Med; 2019 Jul; 8(7):3453-3463. PubMed ID: 31094090 [TBL] [Abstract][Full Text] [Related]
9. Axl activates autocrine transforming growth factor-β signaling in hepatocellular carcinoma. Reichl P; Dengler M; van Zijl F; Huber H; Führlinger G; Reichel C; Sieghart W; Peck-Radosavljevic M; Grubinger M; Mikulits W Hepatology; 2015 Mar; 61(3):930-41. PubMed ID: 25251599 [TBL] [Abstract][Full Text] [Related]
10. Hepatic loss of miR-122 predisposes mice to hepatobiliary cyst and hepatocellular carcinoma upon diethylnitrosamine exposure. Hsu SH; Wang B; Kutay H; Bid H; Shreve J; Zhang X; Costinean S; Bratasz A; Houghton P; Ghoshal K Am J Pathol; 2013 Dec; 183(6):1719-1730. PubMed ID: 24113455 [TBL] [Abstract][Full Text] [Related]
11. Differential expression of Axl in hepatocellular carcinoma and correlation with tumor lymphatic metastasis. He L; Zhang J; Jiang L; Jin C; Zhao Y; Yang G; Jia L Mol Carcinog; 2010 Oct; 49(10):882-91. PubMed ID: 20635370 [TBL] [Abstract][Full Text] [Related]
12. STYK1 promotes epithelial-mesenchymal transition and tumor metastasis in human hepatocellular carcinoma through MEK/ERK and PI3K/AKT signaling. Wang Z; Qu L; Deng B; Sun X; Wu S; Liao J; Fan J; Peng Z Sci Rep; 2016 Sep; 6():33205. PubMed ID: 27628214 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-34a inhibits cell invasion and epithelial-mesenchymal transition via targeting AXL/PI3K/AKT/Snail signaling in nasopharyngeal carcinoma. Jiang C; Cheng Z; Jiang T; Xu Y; Wang B Genes Genomics; 2020 Aug; 42(8):971-978. PubMed ID: 32648233 [TBL] [Abstract][Full Text] [Related]
14. Axl and Mertk Receptors Cooperate to Promote Breast Cancer Progression by Combined Oncogenic Signaling and Evasion of Host Antitumor Immunity. Davra V; Kumar S; Geng K; Calianese D; Mehta D; Gadiyar V; Kasikara C; Lahey KC; Chang YJ; Wichroski M; Gao C; De Lorenzo MS; Kotenko SV; Bergsbaken T; Mishra PK; Gause WC; Quigley M; Spires TE; Birge RB Cancer Res; 2021 Feb; 81(3):698-712. PubMed ID: 33239426 [TBL] [Abstract][Full Text] [Related]
15. Anti-PD-L1 antibodies promote cellular proliferation by activating the PD-L1-AXL signal relay in liver cancer cells. Tanaka T; Koga H; Suzuki H; Iwamoto H; Sakaue T; Masuda A; Nakamura T; Akiba J; Yano H; Torimura T; Kawaguchi T Hepatol Int; 2024 Jun; 18(3):984-997. PubMed ID: 37553470 [TBL] [Abstract][Full Text] [Related]
16. A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target. Tutusaus A; de Gregorio E; Cucarull B; Cristóbal H; Aresté C; Graupera I; Coll M; Colell A; Gausdal G; Lorens JB; García de Frutos P; Morales A; Marí M Cell Mol Gastroenterol Hepatol; 2020; 9(3):349-368. PubMed ID: 31689560 [TBL] [Abstract][Full Text] [Related]
17. Axl Expression Stratifies Patients with Poor Prognosis after Hepatectomy for Hepatocellular Carcinoma. Liu J; Wang K; Yan Z; Xia Y; Li J; Shi L; Zou Q; Wan X; Jiao B; Wang H; Wu M; Zhang Y; Shen F PLoS One; 2016; 11(5):e0154767. PubMed ID: 27182739 [TBL] [Abstract][Full Text] [Related]
18. Axl glycosylation mediates tumor cell proliferation, invasion and lymphatic metastasis in murine hepatocellular carcinoma. Li J; Jia L; Ma ZH; Ma QH; Yang XH; Zhao YF World J Gastroenterol; 2012 Oct; 18(38):5369-76. PubMed ID: 23082053 [TBL] [Abstract][Full Text] [Related]
19. Axl gene knockdown inhibits the metastasis properties of hepatocellular carcinoma via PI3K/Akt-PAK1 signal pathway. Xu J; Jia L; Ma H; Li Y; Ma Z; Zhao Y Tumour Biol; 2014 Apr; 35(4):3809-17. PubMed ID: 24347489 [TBL] [Abstract][Full Text] [Related]
20. Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma. Sadahiro H; Kang KD; Gibson JT; Minata M; Yu H; Shi J; Chhipa R; Chen Z; Lu S; Simoni Y; Furuta T; Sabit H; Zhang S; Bastola S; Yamaguchi S; Alsheikh H; Komarova S; Wang J; Kim SH; Hambardzumyan D; Lu X; Newell EW; DasGupta B; Nakada M; Lee LJ; Nabors B; Norian LA; Nakano I Cancer Res; 2018 Jun; 78(11):3002-3013. PubMed ID: 29531161 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]